Investment analysts at Robert W. Baird started coverage on shares of Oscar Health (NYSE:OSCR – Get Free Report) in a report released on Thursday, Marketbeat reports. The firm set an “outperform” rating and a $28.00 price target on the stock. Robert W. Baird’s price target indicates a potential upside of 40.21% from the stock’s previous […]